Drugs for Her-2-Positive Breast Cancer

by Maria Sibilia

Book Overview

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory anti-HER-2 antibody trastuzumab (Herceptin) for the treatment of HER-2-positive advanced metastatic breast cancer, a new era has dawned in the therapy...

• Format: Paperback
• Language: English
• ISBN: 3034803184
• ISBN13: 9783034803182
• Release Date: February 2013
• Publisher: Springer
• Length: 110 Pages
• Weight: 0.40 lbs.
• Dimensions: 0.3" x 6.1" x 9.2"